2017
$86M
from 11 investors over 11 rounds
Metis Pharmaceuticals Inc raised $75M on April 5, 2022
Investors: CMB International, Morningside Venture Capital 晨兴资本, Lightspeed China Partners, Sequoia Capital China, FreeS Fund 峰瑞资本 and Monolith Management
Metis Pharmaceuticals Inc raised $86M on December 7, 2021
Investors: Lightspeed China Partners, Morningside Venture Capital 晨兴资本 and FreeS Fund 峰瑞资本
Metis Pharmaceuticals Inc raised $15M on December 1, 2020
Investors: Lightspeed China Partners and Sequoia Capital China